Skip to content
2000
Volume 20, Issue 39
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Arterial stiffness is independently associated with increased cardiovascular risk in patients with cardiovascular risk factors and in the general population. Metabolic syndrome (MetS) is frequently characterized by increased arterial stiffness since all components of MetS are implicated in the pathogenesis of arterial stiffness. We review the management of arterial stiffness in patients with MetS. Several small, short-term studies showed that lifestyle changes, antidiabetic, antihypertensive and lipid-lowering agents improve arterial elasticity. However, differences appear to exist between different classes of agents, with statins and inhibitors of the renin-angiotensinaldosterone system having the more favorable effects on arterial stiffness. A multifactorial approach appears to be the optimal management of increased arterial stiffness in patients with MetS.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612820666140417101523
2014-12-01
2025-04-09
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612820666140417101523
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test